Articles by University of British Columbia

Currently, pharmacogenomic tests are not offered through the public health systems across Canada

The discovery could help make the field of immune cell therapy more broadly applicable

The new test is specifically designed to analyze and classify high-grade serous ovarian cancer, the most common and lethal form of ovarian cancer